Polyamine analogue antiarrhythmics

Pharmacological Research

Volumn 38, Issue 5, 1998, Pages 367-380

  Bergeron, Raymond J ^a   Wiegand, Jan ^a   Weimar, William R ^a   Snyder, Patti S ^b  

^a Department of Pharmaceutical Sciences and Experimental Therapeutics   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

Author keywords

Arrhythmia; Electrocardiograph; Isoproterenol; Polyamine; Rat

Indexed keywords

ANTIARRHYTHMIC AGENT; DEOXYCORTICOSTERONE ACETATE; ISOPRENALINE; N1,N3 BIS(4 PYRIDYL) 1,3 DIAMINOPROPANE; NITROGEN; POLYAMINE DERIVATIVE; PROPRANOLOL; PUTRESCINE; PYRIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; PH; POLYAMINE METABOLISM; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032212790     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0384     Document Type: Article

References (31)

1. 1. Wrede F. Spermine III. Hoppe-Seyl Z 1924; 138: 119-35.
2. 2. Tabor H, Tabor CW. Pharmacology of spermine and spermidine. Some effects on animals and bacteria. J Pharmacol 1956; 116: 139-55.
3. 3. Wrede F. Spermine IV. Hoppe-Seyl Z 1926; 153: 291-313.
4. 4. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumors: Antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984; 44: 639-45.
5. 5. Pearce FL, Kassessinoff TA, Liu WL. Characteristics of histamine secretion induced by neuropeptides: Implications for the relevance of peptide-mast cell interactions in allergy and inflammation. Int Arch Allergy App Immunol 1989; 88: 129-31.
6. 6. Amann R, Werle E. On the complexes of heparin with histamine and other di-and polyamines. Klin Wschr 1956; 34: 207-9.
7. 7. Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JRT, Kramer D, Porter C. Antiproliferative properties of polyamine analogues: a structure-activity study. J Med Chem 1994; 37: 3464-76.
8. 8. Bergeron RJ, Neims AH, McManis JS, Hawthorne TW, Vinson JRT, Bortell R, Ingeno MJ. Synthetic polyamine analogues as antineoplastics. J Med Chem 1988; 31: 1183-90.
9. 9. Bernacki RJ, Bergeron RJ, Porter CW. Antitumor activity of N,N′-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res 1992; 52: 2424-30.
10. 10. Bergeron RJ, Weimar WR, Wu Q, Feng Y, McManis JS. Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. J Med Chem 1996; 39: 5257-66.
11. 11-diethylnorspermine. Drug Metab Dispos 1995; 23(10): 1117-25.
12. 14-diethylhomospermine. Drug Metab Dispos 1996; 24(3): 334-43.
13. 13. Porter CW, Miller J, Bergeron RJ. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res 1992; 44: 126-8.
14. 8-spermidine derivatives in cultured L1210 leukemia cells. Cancer Res 1985; 45: 2050-7.
15. 15. Bergeron RJ, Hawthorne TW, Vinson JRT, Beck DE Jr, Ingeno MJ. Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. Cancer Res 1989; 49: 2959-64.
16. 16. Bergeron RJ, McManis JS, Weimar WR, Schreier KM, Gao F, Wu Q, Ortiz-Ocasio J, Luchetta GR, Porter C, Vinson JRT. The role of charge in polyamine analogue recognition. J Med Chem 1995; 38: 2278-85.
17. 12-bis(ethyl-)spermine. Biochem J 1990; 268: 207-12.
18. 18. Pegg AE, Madhubala R, Kameji T, Bergeron RJ. Control of ornithine decarboxylase activity in α-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. J Biol Chem 1988; 263: 11008-14.
19. 19. Porter CW, McManis J, Casero RA, Bergeron RJ. Relative abilities of bis (ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth. Cancer Res 1987; 47: 2821-5.
20. 20. Sninsky CA, Bergeron R. Potent anti-diarrheal activity of a new class of compounds: synthetic analogues of the polyamine pathway. Gastroenterology 1993; 104: A54.
21. 21. Bergeron RJ, Wiegand J, Sninsky CA, Katovich MJ. The impact of polyamine analogues on the blood pressure of normotensive and hypertensive rats. Clin Exp Hypertension 1995: 17(8): 1197-217.
22. 22. Guideri G, Barletta MA, Lehr D. Extraordinary potentiation of isoproterenol cardiotoxicity by corticoid pretreatment. Cardiovasc Res 1974; 8: 775-86.
23. 23. Green M, Guideri G, Lehr D. Effectiveness of antiarrhythmic agents in preventing death in ventricular fibrillation induced by isoprenaline in desoxycorticosterone-pretreated rats. Cardiovasc Res 1983; 17: 562-7.
24. 24. Tagliavini S, Bazzani C, Genedani S, Vergoni AV, Bertolini A. Putrescine has anti-arrhythmic effects in rat models of arrhythmia. Pharm Res 1990; 22(Supp 1): 125-6.
25. 25. Fan C-C, Koenig H. The role of polyamines in β-adrenergic stimulation of calcium influx and membrane transport in rat heart. J Mol Cell Cardiol 1988; 20: 789-99.
26. 26. Busselen P. Polyamines and the calcium paradox in rat hearts. J Mol Cell Cardiol 1991; 23: 237-47.
27. 27. Flamigni F, Rossoni C, Stefanelli C, Caldarera C M. Polyamine metabolism and function in the heart. J Mol Cell Cardiol 1986; 18: 3-11.
28. i and membrane transport in rat heart myocytes. Biochem Biophys Res Comm 1988; 153(3): 1179-85.
29. 1-acetyltransferase in MALME-3M human melanoma cells. J Biol Chem 1993; 268: 19118-25.
30. 1-acetyltransferase by intracelluar polyamine pools-evidence for a functional role in polyamine homeostasis. FEBS Lett 1993; 321: 179-83.
31. i homeostasis and contractility in isolated rat ventricular cardiomyocytes. Am J Physiol 1994; 267: H587-92.